NEW YORK (GenomeWeb News) – Agilent today said Abbott Molecular has granted it a license to manufacture, market, and sell oligonucleotide microarrays using a two-or-more color technology for gene expression and comparative genomic hybridization applications.
The worldwide, non-exclusive license covers the use of microarrays for research, commercial labs, and in vitro diagnostic applications.
Financial details were not disclosed.